About | Free Trial

Last Update

2016-05-01T00:00:00.000Z

This profile was last updated on . .

Is this you? Claim your profile.

Wrong Ingmar Hoerr?

Dr. Ingmar Hoerr

Founder and Chief Executive Officer

CureVac GmbH

Direct Phone: +49 **********       

Email: i***@***.de

CureVac GmbH

210 Broadway Suite 201

Cambridge, Massachusetts 02139

United States

Company Description

CureVac is an integrated biopharmaceutical company with a pipeline of promising drug candidates. Using its RNA technology platform, CureVac is currently developing therapeutic mRNA vaccines (RNActive®) and vaccine adjuvants, comprised of long, non-coding ... more

Find other employees at this company (75)

Background Information

Employment History

MBA Fellow, Executive Ass. To Chief Executive Officer
EMC microcollections

Affiliations

Advisory Board Member
DN Capital

Education

MBA

Danube University

MBA

Danube University of Krems

PhD

University of Tübingen

PhD
biology
Tuebingen University

Web References (151 Total References)


curevac.de: Company

www.curevac.com [cached]

In the late 1990s, Dr. Ingmar Hoerr, Co-founder and CEO of CureVac, made an unexpected discovery during his doctoral research in biology, which was contrary to the established scientific belief at the time: RNA, which was generally thought to be a very unstable biomolecule, could be administered directly into tissue as a therapeutic vaccine or agent once the biological properties of the molecule were appropriately modified. Furthermore, complicated formulations or molecular packaging were not required to achieve these results.

This discovery led to a new fundamental understanding of the potential of RNA to treat diseases and to generate prophylactic immunity. These fascinating possibilities prompted the company's three founders, Ingmar Hoerr, Steve Pascolo and Florian von der Mülbe, to found CureVac without investors during the difficult market environment of 2000.


Dr. Ingmar Hoerr, CEO of ...

www.curevac.com [cached]

Dr. Ingmar Hoerr, CEO of CureVac, said "I believe these new results are excellent news for patients.


Ingmar Hoerr, PhD, ...

www.curevac.com [cached]

Ingmar Hoerr, PhD, MBA Chairman / Chief Executive Officer

...
From this key discovery, Ingmar Hoerr and Florian von der Mülbe built up a company that is now a global leader in the research and development of mRNA-based drugs.
...
Ingmar Hoerr received his PhD from the University of Tübingen and his MBA from Danube University, Krems, Austria.
...
Florian worked with Biotest GmbH and Roche AG before joining CureVac in 2000 - working with Ingmar Hoerr to build the business from the start.


Ingmar Hoerr, PhD, ...

www.curevac.com [cached]

Ingmar Hoerr, PhD, co-founder and CEO of CureVac, said, "We are delighted to welcome these esteemed experts to CureVac's Scientific Advisory Board during this time of significant growth and progress for CureVac.


Ingmar Hoerr, Ph.D., ...

www.curevac.com [cached]

Ingmar Hoerr, Ph.D., co-founder and CEO of CureVac, stated, "We are pleased to welcome these highly-respected experts to CureVac's supervisory board as we continue to advance our mRNA-based medicines to address significant therapeutic needs and global market opportunities."

Similar Profiles

Other People with this Name

Other people with the name Hoerr

Jutta Hoerr
Evonik Industries AG

Mark Hoerr
Mark Hoerr Landscaping INC

Harry Hoerr
Midwestern University

Douglas Hoerr
University of Wisconsin

Dorothy Hoerr
Brunswick County Literacy Council

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory